Century Therapeutics (IPSC) Leases (2022 - 2025)
Historic Leases for Century Therapeutics (IPSC) over the last 4 years, with Q3 2025 value amounting to $16.6 million.
- Century Therapeutics' Leases fell 4253.5% to $16.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.6 million, marking a year-over-year decrease of 4253.5%. This contributed to the annual value of $28.7 million for FY2024, which is 4088.14% up from last year.
- As of Q3 2025, Century Therapeutics' Leases stood at $16.6 million, which was down 4253.5% from $27.7 million recorded in Q2 2025.
- Over the past 5 years, Century Therapeutics' Leases peaked at $29.5 million during Q3 2022, and registered a low of $11.7 million during Q1 2022.
- Moreover, its 4-year median value for Leases was $27.7 million (2025), whereas its average is $24.7 million.
- As far as peak fluctuations go, Century Therapeutics' Leases surged by 14170.52% in 2023, and later plummeted by 4253.5% in 2025.
- Century Therapeutics' Leases (Quarter) stood at $28.9 million in 2022, then fell by 29.6% to $20.4 million in 2023, then surged by 40.88% to $28.7 million in 2024, then crashed by 42.29% to $16.6 million in 2025.
- Its Leases was $16.6 million in Q3 2025, compared to $27.7 million in Q2 2025 and $28.2 million in Q1 2025.